Aimei Health TechnologyAFJK

13F holders, Q1 2026 (March 31)
8holders −3
1new positions
5sold out
$11.39avg. 13F price*

At the end of Q1 2026, 8 institutions reported holding Aimei Health Technology Co. (AFJK) in their 13F filings, down 3 from Q4 2025. 1 opened new positions and 5 sold out. The largest holders were First Trust Capital Management L.P. ($7.7M), Glazer Capital, LLC ($1.5M) and Clear Street Group Inc. ($948K).

Company
Aimei Health Technology Co.
CUSIP
G01341109
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q1 2024: 26Q1 2024Q2 2024: 30Q2 2024Q3 2024: 31Q3 2024Q4 2024: 23Q4 2024Q1 2025: 16Q1 2025Q2 2025: 16Q2 2025Q3 2025: 17Q3 2025Q4 2025: 11Q4 2025Q1 2026: 8Q1 2026Q2 2026: 7Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions1$5K
Exits5$1.1M

All 13F filers, Q4 2025 → Q1 2026: 203 shares bought and 20,417 shares sold, net −20,214 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 8 holders

First Trust Capital Management L.P. 0.41% No change 680,000 $7.7M
Glazer Capital, LLC 0.03% No change 133,744 $1.5M
Clear Street Group Inc. 0.01% No change 83,337 $948K
Karpus Management, Inc. 0.03% Reduce -1.2% 77,125 $888K
Osaic Holdings, Inc. 0.00% Reduce -72.4% 238 $6K
Federation des caisses Desjardins du Quebec 0.00% New 185 $5K
Morgan Stanley 0.00% Add +56.3% 50 $1K
UBS Group AG 0.00% Reduce -98.9% 14 $343

"% of holder's portfolio" is AFJK's weight in each manager's 13F, not the share of Aimei Health Technology Co. the manager owns.